ConductScience.org, home

Paper24802401

Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion.

Zhang S and 2 others. Biochem Biophys Res Commun, 2014. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion. Papers, record 24802401. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24802401

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion.
PubMed
Journal
Biochem Biophys Res Commun
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
1.44
iCite
Revised in PubMed
2014-06-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang SShangrong
2Wang YYifan
3Li SJShu Jie

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApoptosisMajor topic
Breast NeoplasmsMajor topic
LansoprazoleMajor topic
Adenosine Triphosphate
Animals
Cell Line, Tumor
Female
Humans
Hydrogen-Ion Concentration
Lysosomes
Mice
Mice, Nude
Proton Pump Inhibitors
Protons
Reactive Oxygen Species
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
42789078Pantoprazole as a potential repurposed drug targeting the adenosinergic system in esophageal cancer.Med Chem Res2026https://conductscience.org/library/papers/42789078PubMed
39671131Association Between Clinical Use of Lansoprazole and the Risk of Coronary Heart Disease: A Nationwide Pharmacoepidemiological Cohort Study.Cardiovasc Drugs Ther2025https://conductscience.org/library/papers/39671131PubMed
37999256
Assessing the Therapeutic Efficacy of Proton Transport Inhibitors in a Triple-Negative Breast Cancer Murine Model with Magnetic Resonance Imaging-Chemical Exchange Saturation Transfer Tumor pH Imaging.
Metabolites2023https://conductscience.org/library/papers/37999256PubMed
37989907Lansoprazole inhibits the development of sessile serrated lesions by inducing G1 arrest via Skp2/p27 signaling pathway.J Gastroenterol2024https://conductscience.org/library/papers/37989907PubMed
37232870Development of Levo-Lansoprazole Chiral Molecularly Imprinted Polymer Sensor Based on the Polylysine-Phenylalanine Complex Framework Conformational Separation.Biosensors (Basel)2023https://conductscience.org/library/papers/37232870PubMed
37213670Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition.Int J Med Sci2023https://conductscience.org/library/papers/37213670PubMed
37165435Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study.Diabetol Metab Syndr2023https://conductscience.org/library/papers/37165435PubMed
36701089Involvement of redox signalling in tumour cell dormancy and metastasis.Cancer Metastasis Rev2023https://conductscience.org/library/papers/36701089PubMed
36676972Effect of Esomeprazole Treatment on Extracellular Tumor pH in a Preclinical Model of Prostate Cancer by MRI-CEST Tumor pH Imaging.Metabolites2022https://conductscience.org/library/papers/36676972PubMed
36297518Proposal to Consider Chemical/Physical Microenvironment as a New Therapeutic Off-Target Approach.Pharmaceutics2022https://conductscience.org/library/papers/36297518PubMed
36230838In Vivo MRI-CEST Tumor pH Imaging Detects Resistance to Proton Pump Inhibitors in Human Prostate Cancer Murine Models.Cancers (Basel)2022https://conductscience.org/library/papers/36230838PubMed
36046070The impact of tumour pH on cancer progression: strategies for clinical intervention.Explor Target Antitumor Ther2020https://conductscience.org/library/papers/36046070PubMed
35800371The complex relationship between multiple drug resistance and the tumor pH gradient: a review.Cancer Drug Resist2022https://conductscience.org/library/papers/35800371PubMed
35256749Naturally occurring deamidated triosephosphate isomerase is a promising target for cell-selective therapy in cancer.Sci Rep2022https://conductscience.org/library/papers/35256749PubMed
33959611Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo.Front Cell Dev Biol2021https://conductscience.org/library/papers/33959611PubMed
33948872Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition.Cell Oncol (Dordr)2021https://conductscience.org/library/papers/33948872PubMed
33394214Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma.Med Oncol2021https://conductscience.org/library/papers/33394214PubMed
33287221Targeting the pH Paradigm at the Bedside: A Practical Approach.Int J Mol Sci2020https://conductscience.org/library/papers/33287221PubMed
33173988Macrolide antibiotics enhance the antitumor effect of lansoprazole resulting in lysosomal membrane permeabilization‑associated cell death.Int J Oncol2020https://conductscience.org/library/papers/33173988PubMed
32485921Effect of Proton Pump Inhibitors on Colorectal Cancer.Int J Mol Sci2020https://conductscience.org/library/papers/32485921PubMed

See all 33 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24802401

GET https://conductscience.org/api/papers/v1/24802401/cited_by?page=2